Form D · Biotechnology
AIT Bioscience, LLC
Indianapolis, IN · CIK 0001595728
Offering snapshot reported Jan 6, 2015 · SEC filing
- Reported sold
- $500K Offering amount: $1M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Dec 31, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 6, 2015 | Initial | $500,000 | No comparison | 4 | SEC filing |
| Jan 7, 2014 | Initial | $1,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-231524
Source: Form D, filed Jan 6, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John H. Barnard | Director |
| Michael A. Evans | Director, Executive |
| Jonathon Fruchte | Director |
| John Michael Irons | Director |
| R. J. Mc Connell | Director |
| Teresa A. Pascarelli | Director, Executive |
| Ronald E. Shoup | Director, Executive |
| Terry J. Spartz | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7840 Innovation Boulevard
Indianapolis, IN, 46278
Indianapolis, IN, 46278